Abstract
Human myeloid leukemic cells usually fail to grow or differentiate in vitro. The ability of cytokines to stimulate leukemic cell proliferation was first shown in well-differentiated T-cell leukemias using interleukin-2 (Poiesz et al., 1980). However, the role of hematopoietic growth factors in the initiation or progression of myeloid leukemic cells is not clear. A small fraction of almost all human myeloid leukemic cells show a proliferate response to one of these growth factors-IL-1, IL-3, CSF-1 GM-CSF or G-CSF (Griffin et al., 1986; Pebusque et al., 1988). These responding cells usually undergo terminal differentiation and cease cell proliferation. In rare cases, permanent cell lines which are usually factor independent can be established (Ferraro and Rovera, 1984). The question of why these hematopoietic growth factors can not control the growth and differentiation of leukemic cells remains unanswered. Making the assumption that the ability of these factors to transduce the correct biochemical signals was compromised in these cells, we asked whether differentiation signals that bypassed the cell membrane could stimulate terminal differentiation. In addition, since loss of responsiveness to growth inhibitors such as TGF-3 has been proposed to contribute to neoplastic growth of various cell types, we examined the role of TGF-3 in myeloid leukemic growth.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bettens, F., Schlick, E., Farrar, W., Ruscetti, F. (1986) 1,25 dihydroxychole-calciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony-stimulating factors and phorbol esters. J. Cell. Physiol. 129:295–302.
Burgess AW, Metcalf D (1980). The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56:947.
Collins, S. (1987) The HL-60 promyelocytic leukemia cell line: proliferation, differentiation and cellular oncogene expression. Blood 70:1233–1241.
Ferrero, D., Rovera, G. (1984) Human leukemic cell lines. Clin. Hematol. 13: 1461–1484.
Griffin, J., Younf, D., Hermann, F., Wiper, D., Wagner, K., Sabbath, K. (1986) Effect of recombinant GM-CSF on proliferation of clonogenic cells in acute myelogenous leukemia. Blood 67:1448–1455.
Keller JR, Mantel C, Sing G, Ellingsworth LE, Ruscetti SK, Ruscetti FW (1988) Transforming growth factor β1 selectively regulates early murine hematopoietic progenitors and inhibits the growth of IL-3 dependent myeloid leukemia cell lines. J. Exp. Med. 168:737–750, 1988.
McCarthy, D., San Miguel, J., Freake, H., Green, P., Zola, H., Catovsky, D., Goldman, J. (1983) 1,25 Dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL-60) cells and induces monocytic-macrophage differentiation in HL-60 and normal human bone marrow cells. Leukemia Res., 7:51–55.
Nicola, N. A., and D. Metcalf (1984) Binding of the differentiation-inducer, granulocyte-colony stimulating factor to responsive but not unresponsive leukemic cell lines. Proc. Natl. Acad. Sci. U.S.A., 81: 3765–3769.
Pebusque, M., Lopez, M., Torres, H., Carotti, A., Guibert, L., Mannoni, P (1988) Growth response of human myeloid leukemic cells to colony stimulating factors Exp. Hematol. 16:360–366.
Poiesz, B., Ruscetti, F., Mier, J., Woods, A., Gallo, R. (1980) T-cell lines established from human T-cell lymphocytic neoplasia by direct response to T-cell growth factor. Proc. Natl. Acad. Sci. USA 77:6815–6819.
Ralph, P., Moore, M. A. S. and Nilsson, K (1976) Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J. Exp. Med., 143: 1528–1533.
Sing G, Keller JR, Ellingworth LE, Ruscetti FW (1988) Transforming Growth Factor 3 selectively inhibits normal and leukemic human bone marrow growth in vitro. Blood 72:1504–1509, 1988
Sporn MB, Roberts AB, Lalage MW, Assoian MA, (1986) Transforming growth factor-β: Biological function and chemical structure. Science 233:532.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Ruscetti, F. et al. (1989). Role of Biologic Response Modifiers in the Growth and Differentiation of Myeloid Leukemic Cells. In: Shen-Ong, G.L.C., Potter, M., Copeland, N.G. (eds) Mechanisms in Myeloid Tumorigenesis 1988. Current Topics in Microbiology and Immunology, vol 149. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74623-9_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-74623-9_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74625-3
Online ISBN: 978-3-642-74623-9
eBook Packages: Springer Book Archive